Abstract:Yupeng Han, 1, 2, &ast Liangcheng Qiu, 1, 2, &ast Haixing Wu, 1, 2, &ast Zhiwei Song, 3 Peng Ke, 1, 2 Xiaodan Wu 1, 2 1 Department of Anesthesiology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China; 2 Fujian Provincial Key Laboratory of Critical Care Medicine, Fuzhou, Fujian, People's Republic of China; 3 Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaodan Wu, Department of Anesthesiology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China, Email Sepsis is a severe systemic inflammatory response commonly occurring in infectious diseases, caused by infection with virulent pathogens. In the pathogenesis of sepsis, the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) signaling pathway serves a crucial role as a fundamental immunoregulatory mechanism. This signaling pathway activates STING upon recognizing intracellular DNA damage and pathogen-derived DNA, subsequently inducing the production of numerous inflammatory mediators, including interferon and inflammatory cytokines, which in turn trigger an inflammatory response. The aim of this paper is to explore the activation mechanism of the cGAS-STING signaling pathway in sepsis and its impact on inflammatory regulation. By delving into the mechanism of action of the cGAS-STING signaling pathway in sepsis, we aim to identify new therapeutic strategies for the treatment and prevention of sepsis. Keywords: sepsis, cGAS, STING, inflammation Sepsis is a critical condition characterized by multi-organ dysfunction and potentially leading to organ failure, resulting from an over-activated inflammatory response triggered by infection. Furthermore, host immune dysfunction, attributed to this excessive inflammatory response, is closely associated with increased mortality rates in sepsis patients. 1–3 The excessive inflammatory response and the ensuing cytokine storm have been long identified as primary contributors to the elevated mortality rates among sepsis patients. 4,5 However, recent years have seen that drugs targeting cytokine receptors, including Tumor necrosis factor-α (TNF-α), Interleukin-1β (IL-1β), and others, have failed to significantly improve clinical outcomes in sepsis patients. 6,7 Recent research has elucidated that both innate immune dysfunction and acquired immunosuppression are of equal importance in contributing to the multiorgan failure and mortality associated with sepsis. 8 Consequently, preserving the normal functionality of both innate and acquired immune mechanisms is pivotal for the effective treatment of sepsis. 3,9 In recent years, research into the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) signaling pathway has been extensive, highlighting its critical role in sensing aberrant intracellular DNA and triggering the host's immune response. 10,11 Current research indicates that aberrant activation of this pathway may induce significant production of type I interferon (IFN-I) and other inflammatory cytokines, potentially influencing the onset and progression of the body's inflammatory response. In the pathological context of sepsis, infection-induced cell death or tissue damage results in the release of large amounts of DNA into the cytoplasm, with the activation of the cGAS-STING signaling pathway potentially serving as a crucial regulatory point in the inflammatory response. 12 However, the role of the cGAS-STING signaling pathway in sepsis and its regulatory mechanisms in the pathophysiological process of sepsis development have not been fully elucidated. In this article, we review the current research status of the cGAS-STING signaling pathway in the occurrence and development of sepsis as reported in previous studies. We also explore its application in the treatment of sepsis, aiming to provide valuable insights for future therapeutic strategies and research directions. The cGAS-STING signaling pathway is an important signaling pathway involved in the immune response, initiating the immune response by recognizing aberrant intracellular DNA. Its aberrant activation or dysregulation has been demonstrated to closely associate with the development of various diseases, including infect -Abstract Truncated-

Gelsevirine is a novel STING-specific inhibitor and mitigates STING-related inflammation in sepsis

Gelsevirine ameliorates sepsis-associated encephalopathy by inhibiting the STING signalling-mediated pyroptosis pathway in microglia

A Novel Transcript Isoform of STING That Sequesters Cgamp and Dominantly Inhibits Innate Nucleic Acid Sensing

Glycyrrhiza uralensis polysaccharides ameliorates cecal ligation and puncture-induced sepsis by inhibiting the cGAS-STING signaling pathway

STING inhibitors target the cyclic dinucleotide binding pocket

C-176 inhibits macrophage polarization towards M1-subtype and ameliorates LPS induced acute kidney injury

Protective Effect of Ginsenosides Rg1 and Re on Lipopolysaccharide-Induced Sepsis by Competitive Binding to Toll-like Receptor 4.

Development of an orally bioavailable covalent STING inhibitor

Focus on the cGAS-STING Signaling Pathway in Sepsis and Its Inflammatory Regulatory Effects

Structure−Activity Relationship Study of Benzothiophene Oxobutanoic Acid Analogues Leading to Novel Stimulator of Interferon Gene (STING) Agonists

A novel STING agonist with systemic and durable anti-tumour activity

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist

Prolonged activation of innate immune pathways by a polyvalent STING agonist

The interaction between STING and NCOA4 exacerbates lethal sepsis by orchestrating ferroptosis and inflammatory responses in macrophages

Discovery of triazoloquinoxaline as novel STING agonists via structure-based virtual screening

The emerging role of stimulator of interferons genes signaling in sepsis: Inflammation, autophagy, and cell death

Activation of human STING by a molecular glue-like compound

Targeting STING oligomerization with small-molecule inhibitors

4-Octyl Itaconate As a Metabolite Derivative Inhibits Inflammation Via Alkylation of STING

Bis-N-norgliovictin, a small-molecule compound from marine fungus, inhibits LPS-induced inflammation in macrophages and improves survival in sepsis.